Read more about the article Amgen is Not the End of Chemical Innovation
Genetic research and Biotech science Concept. Human Biology and pharmaceutical technology on laboratory background.

Amgen is Not the End of Chemical Innovation

By Dominic A. Frisina Some chemical innovators have found the recent Supreme Court decision in Amgen v. Sanofi to suggest that chemical inventions will be subject to new and draconian disclosure…

Continue ReadingAmgen is Not the End of Chemical Innovation

“Active Clinical Practice” Requirements for Expert Witnesses Now Evaluated at the Time of Alleged Malpractice

  • Post author:
  • Post category:Blog

In recent years, issues surrounding the admissibility of expert witness testimony in medical malpractice matters have been more prevalent than ever. In general, Ohio law mandates that medical claims are…

Continue Reading“Active Clinical Practice” Requirements for Expert Witnesses Now Evaluated at the Time of Alleged Malpractice
Read more about the article Amgen Ratifies CAFC’s Requirement to Enable a Claim’s Full Scope
Close up of human hands. Man holding the medicine bottle in one hand and pill in other

Amgen Ratifies CAFC’s Requirement to Enable a Claim’s Full Scope

By Dominic A. Frisina, and Hannah P. Mink The Court’s reasoning in Amgen v. Sanofi upholds the Federal Circuit’s long-standing requirement to enable the full scope of a claimed invention.…

Continue ReadingAmgen Ratifies CAFC’s Requirement to Enable a Claim’s Full Scope